EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High Diagnostic Yield and Clinical Utility of Next-Generation Sequencing in Children with Epilepsy and Neurodevelopmental Delays: A Retrospective Study

Daniel Charouf, Derryl Miller, Laith Haddad iD, Fletcher A White iD, Rose-Mary Boustany iD, Makram Obeid iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Daniel Charouf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Child Neurology, Department of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Riad El Solh, Beirut P.O.…. Hauptthemen laut MEDLINE: Epilepsy, High-Throughput Nucleotide Sequencing, Developmental Disabilities, Exome Sequencing. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in genetics led to the identification of hundreds of epilepsy-related genes, some of which are treatable with etiology-specific interventions. However, the diagnostic yield of next-generation sequencing (NGS) in unexplained epilepsy is highly variable (10–50%). We sought to determine the diagnostic yield and clinical utility of NGS in children with unexplained epilepsy that is accompanied by neurodevelopmental delays and/or is medically intractable. A 5-year retrospective review was conducted at the American University of Beirut Medical Center to identify children who underwent whole exome sequencing (WES) or whole genome sequencing (WGS). Data on patient demographics, neurodevelopment, seizures, and treatments were collected. Forty-nine children underwent NGS with an overall diagnostic rate of 68.9% (27/38 for WES, and 4/7 for WGS). Most children (42) had neurodevelopmental delays with (18) or without (24) refractory epilepsy, and only three had refractory epilepsy without delays. The diagnostic yield was 77.8% in consanguineous families (18), and 61.5% in non-consanguineous families (26); consanguinity information was not available for one family. Genetic test results led to anti-seizure medication optimization or dietary therapies in six children, with subsequent improvements in seizure control and neurodevelopmental trajectories. Not only is the diagnostic rate of NGS high in children with unexplained epilepsy and neurodevelopmental delays, but also genetic testing in this population may often lead to potentially life-altering interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyHigh-Throughput Nucleotide SequencingDevelopmental DisabilitiesExome SequencingHumansMaleFemaleChildChild, PreschoolRetrospective StudiesInfantNeurodevelopmental DisordersGenetic TestingAdolescentWhole Genome Sequencing

Stichwörter der Autor:innen

epilepsygenetic yieldneurodevelopmental delaysnext-generation sequencingrefractory seizures

Autor:innen und Institutionen

  • Division of Child Neurology, Department of Pediatric and Adolescent Medicine, American University of Beirut Medical Center, Riad El Solh, Beirut P.O. Box 11-0236, Lebanon.
  • Division of Child Neurology, Department of Neurology, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN 46202, USA.
  • Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Biochemistry, Faculty of Medicine, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon.

ORCID-Profile: Laith Haddad, Fletcher A White, Rose-Mary Boustany, Makram Obeid

Zitieren

APA

Charouf, D., Miller, D., Haddad, L., White, F. A., Boustany, R. M., & Obeid, M. (2024). High Diagnostic Yield and Clinical Utility of Next-Generation Sequencing in Children with Epilepsy and Neurodevelopmental Delays: A Retrospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179645

Vancouver

Charouf D, Miller D, Haddad L, White FA, Boustany RM, Obeid M. High Diagnostic Yield and Clinical Utility of Next-Generation Sequencing in Children with Epilepsy and Neurodevelopmental Delays: A Retrospective Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179645

BibTeX
@article{Charouf2024,
  author = {Charouf, Daniel and Miller, Derryl and Haddad, Laith and White, Fletcher A and Boustany, Rose-Mary and Obeid, Makram},
  title = {High Diagnostic Yield and Clinical Utility of Next-Generation Sequencing in Children with Epilepsy and Neurodevelopmental Delays: A Retrospective Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179645}
}
Kostenlos starten →